BUND FINANCE

BUND FINANCE › Stocks › ALC

Alcon Inc. (ALC)

NYSE · Stock price, chart and technical analysis

US$75.26+1.15 (+1.55%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$74.11
OpenUS$73.41
Day rangeUS$73.35 – US$75.51
52-week rangeUS$61.84 – US$87.64
Market capUS$36.15B
Volume4.74M
50-day averageUS$68.14
200-day averageUS$71.58
Beta0.72
Last dividend per shareUS$0.3593

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$8.3BUS$8.7BUS$9.5BUS$9.9BUS$10.4B
Net incomeUS$376.0MUS$335.0MUS$974.0MUS$1.0BUS$980.0M
EPS (diluted)0.760.681.962.051.98
Gross margin56.1%54.5%55.5%55.6%55.2%
Operating margin7.0%7.7%11.0%14.3%13.1%
Net margin4.5%3.8%10.3%10.3%9.4%
Free cash flowUS$165.0MUS$472.0MUS$537.0MUS$1.4BUS$1.6B
Total debtUS$4.5BUS$5.1BUS$5.1BUS$5.1BUS$5.2B
CashUS$1.6BUS$980.0MUS$1.1BUS$1.7BUS$1.5B

Compound annual growth: revenue 5.8% · net income 27.1% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E55.3x66.8x27.1x
EV / EBITDA14.3x20.1x16.5x
Operating margin10.2%—3.6%
Net margin6.1%—-0.0%
Debt / equity0.44—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Alcon Inc.

SectorHealthcare
IndustryMedical - Specialties
CountryCH
CEODavid J. Endicott
Employees25,000
IPO date2019-04-09

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative m…

www.alcon.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice